Insiders / Ashiya Mona
Ashiya Mona
CIK 1794070personinsider
Companies
4
First seen
Jun 9, 2021
Last activity
Jul 29, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Shattuck Labs, Inc. · STTK | 1,051,021 | — |
| Sierra Oncology, Inc. · SRRA | 226,704 | — |
| Gemini Therapeutics, Inc. /DE · GMTX | 186,541 | — |
| VYNE Therapeutics Inc. · VYNE | 33,287 | — |
All securities held
7 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Gemini Therapeutics, Inc. /DE | Common stock | 186,541 |
| Shattuck Labs, Inc. | Common stock | 1,051,021 |
| Sierra Oncology, Inc. | Common stock | 226,704 |
| VYNE Therapeutics Inc. | Common stock | 33,287 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Gemini Therapeutics, Inc. /DE | Options | 10,000 |
| Shattuck Labs, Inc. | Options | 5,384,908 |
| VYNE Therapeutics Inc. | Options | 15,435 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jul 1, 2022 | Other Sold to issuer | SRRA Sierra Oncology, Inc. Common Stock | $83.12M | -1.5M -100.00% | 0 | low |
| Dec 14, 2023 | Sell Open-market sale | GMTX Gemini Therapeutics, Inc. /DE Common Stock | $12.97M | -229K -20.29% | 897,625 2.34% of shares | high |
| Jul 1, 2022 | Other Sold to issuer | SRRA Sierra Oncology, Inc. Common Stock | $12.47M |